Mark Harber
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 14
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 5
- Epidemiology top 10%
- Cytomegalovirus and herpesvirus research 9
- Herpesvirus Infections and Treatments 6
- Urinary Tract Infections Management 5
- Infectious Diseases top 10%
-
- Pediatric Urology and Nephrology Studies 5
-
- Organ Donation and Transplantation 4
-
- Polyomavirus and related diseases 4
Mark Harber
51 papers receiving 880 citations
Peers
Comparison fields: 5 of 98
- Transplantation 182
- Nephrology 150
- Epidemiology 352
- Infectious Diseases 174
- Immunology 142
Countries citing papers authored by Mark Harber
This map shows the geographic impact of Mark Harber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harber more than expected).
Fields of papers citing papers by Mark Harber
This network shows the impact of papers produced by Mark Harber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harber. The network helps show where Mark Harber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Harber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2021 | 31 | |
| 6 | 2021 | 15 | |
| 7 | 2020 | 11 | |
| 8 | 2020 | 15 | |
| 9 | 2019 | 26 | |
| 10 | 2018 | 24 | |
| 11 | 2018 | 11 | |
| 12 | UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis. | 2017 | 28 |
| 13 | 2016 | 21 | |
| 14 | 2016 | 18 | |
| 15 | 2015 | 25 | |
| 16 | 2014 | 5 | |
| 17 | 2014 | 7 | |
| 18 | Fulminant hepatitis following primary herpes simplex virus infection in renal transplant recipients | 2011 | 7 |
| 19 | 2008 | 6 | |
| 20 | 1994 | 2 |
About Mark Harber
Mark Harber is a scholar working on Transplantation, Nephrology and Epidemiology, having authored 53 papers that have together received 888 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (14 papers), Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (6 papers), Renal Diseases and Glomerulopathies (5 papers), Pediatric Urology and Nephrology Studies (5 papers), Urinary Tract Infections Management (5 papers), Organ Donation and Transplantation (4 papers) and Polyomavirus and related diseases (4 papers). The work is most often cited by research in Transplantation (182 citations), Nephrology (150 citations) and Epidemiology (352 citations). Mark Harber has collaborated with scholars based in United Kingdom, Egypt and United States. Frequent co-authors include Claire Atkinson, Colette Smith, Paul Griffiths, Douglas Thorburn, A. Burns, Vincent C. Emery, P. Sweny, Sowsan Atabani, James O’Beirne and David C. Wraith. Their work appears in journals such as Nephrology Dialysis Transplantation, Transplantation, PLoS ONE, Kidney International and International Journal of STD & AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.